SI9300309A - Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo - Google Patents

Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo Download PDF

Info

Publication number
SI9300309A
SI9300309A SI9300309A SI9300309A SI9300309A SI 9300309 A SI9300309 A SI 9300309A SI 9300309 A SI9300309 A SI 9300309A SI 9300309 A SI9300309 A SI 9300309A SI 9300309 A SI9300309 A SI 9300309A
Authority
SI
Slovenia
Prior art keywords
formula
piperazine
wavy line
nitrogen
group
Prior art date
Application number
SI9300309A
Other languages
English (en)
Slovenian (sl)
Inventor
Zoltan Tuba
Sandor Maho
Aniko Gere
Pal Vittay
Bela Kiss
Eva Palosi
Laszlo Szporny
Csaba Szantay
Ferenc Soti
Roj Kardos Zsuzsa Balogh
Maria Incze
Gabor Balogh
Maria Gazdag
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of SI9300309A publication Critical patent/SI9300309A/sl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D461/00Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SI9300309A 1992-06-09 1993-06-09 Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo SI9300309A (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9201911A HU209678B (en) 1992-06-09 1992-06-09 Process for producing biologically active eburnamenin-14-carbonyl-amino derivatives and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
SI9300309A true SI9300309A (sl) 1993-12-31

Family

ID=10982021

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9300309A SI9300309A (sl) 1992-06-09 1993-06-09 Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo

Country Status (18)

Country Link
US (1) US5510345A (et)
EP (1) EP0644885A1 (et)
JP (1) JPH07507793A (et)
KR (1) KR950701924A (et)
AU (1) AU4352493A (et)
CA (1) CA2136547A1 (et)
CZ (1) CZ307994A3 (et)
EE (1) EE9400070A (et)
FI (1) FI945780A (et)
GR (1) GR1001597B (et)
HR (1) HRP930957A2 (et)
HU (1) HU209678B (et)
IL (1) IL105942A0 (et)
LT (1) LT3118B (et)
NZ (1) NZ253308A (et)
SI (1) SI9300309A (et)
WO (1) WO1993025550A1 (et)
ZA (1) ZA934037B (et)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200626155A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
TW200626154A (en) 2004-09-20 2006-08-01 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as therapeutic agents
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
BRPI0515478A (pt) 2004-09-20 2008-07-22 Xenon Pharmaceuticals Inc derivados heterocìclicos e seu uso como mediadores de estearoil-coa-desaturase
AU2005329423A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CN101083982A (zh) 2004-09-20 2007-12-05 泽农医药公司 用于治疗硬脂酰CoA去饱和酶介导的疾病的杂环衍生物
WO2006034279A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
RU2007110731A (ru) * 2004-09-23 2008-10-27 Редди Юс Терапевтикс Новые соединения пиримидина, способ их получения и содержащие их композиции
BRPI0611187A2 (pt) 2005-06-03 2010-08-24 Xenon Pharmaceuticals Inc derivados aminotiazàis como inibidores da estearoil-coa desaturase humana
US20110053907A1 (en) * 2008-03-27 2011-03-03 Auckland Uniservices Limited Substituted pyrimidines and triazines and their use in cancer therapy
CN101928286A (zh) * 2009-06-18 2010-12-29 谢开智 长春胺衍生物及制备方法
AU2014249003A1 (en) 2013-03-13 2015-10-15 Forma Therapeutics, Inc. Novel compounds and compositions for inhibition of FASN
AU2017275657B2 (en) 2016-06-02 2021-08-19 Novartis Ag Potassium channel modulators
RS62899B1 (sr) 2017-01-23 2022-03-31 Cadent Therapeutics Inc Modulatori kalijumovih kanala
CA3116339A1 (en) 2018-10-22 2020-04-30 Cadent Therapeutics, Inc. Crystalline forms of potassium channel modulators
US10793554B2 (en) 2018-10-29 2020-10-06 Forma Therapeutics, Inc. Solid forms of 4-(2-fluoro-4-(1-methyl-1H-benzo[d]imidazol-5-yl)benzoyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2176516B1 (et) * 1972-03-22 1975-03-14 Synthelabo
HU171663B (hu) * 1975-09-01 1978-02-28 Richter Gedeon Vegyeszet Sposob poluchenija novykh proizvodnykh 14-skobka-zamehhennogo metil-skobka zakryta-vinkana
US4547505A (en) * 1983-03-25 1985-10-15 Degussa Aktiengesellschaft N-Phenyl-N-'-cycloalkylalkanoylpiperazine useful as analgetics and process for its production
WO1987001706A2 (en) 1985-09-12 1987-03-26 The Upjohn Company C20 through c26 amino steroids
US5099019A (en) * 1985-09-12 1992-03-24 Upjohn Company Amines useful in producing pharmaceutically active CNS compounds
WO1987007895A1 (en) 1986-06-23 1987-12-30 The Upjohn Company Androstane-type and cortical aminoesters
KR890700581A (ko) 1987-04-03 1989-04-25 로버어트 에이 아미테이지 아미노 -9,10-세코스테로이드
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
FR2644788B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 3-ceto comportant une chaine en 17 amino-substituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644787B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 21 aminosubstitues, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2644789B1 (fr) 1989-03-22 1995-02-03 Roussel Uclaf Nouveaux steroides 19-nor, 3-ceto comportant une chaine en 17 aminosubstituee, leur procede de preparation et les intermediaires de ce procede, leur application comme medicaments et les compositions pharmaceutiques les contenant
JPH05503705A (ja) 1990-01-26 1993-06-17 ジ・アップジョン・カンパニー 5―酸素化―2,4,6―トリアミノピリミジン類

Also Published As

Publication number Publication date
HU9201911D0 (en) 1992-09-28
HUT64540A (en) 1994-01-28
IL105942A0 (en) 1993-10-20
EP0644885A1 (en) 1995-03-29
CZ307994A3 (en) 1995-07-12
LTIP599A (en) 1994-07-15
AU4352493A (en) 1994-01-04
HU209678B (en) 1994-10-28
CA2136547A1 (en) 1993-12-23
ZA934037B (en) 1994-01-06
LT3118B (en) 1994-12-27
FI945780A0 (fi) 1994-12-08
JPH07507793A (ja) 1995-08-31
GR1001597B (el) 1994-06-30
KR950701924A (ko) 1995-05-17
EE9400070A (et) 1995-12-15
HRP930957A2 (en) 1995-02-28
WO1993025550A1 (en) 1993-12-23
US5510345A (en) 1996-04-23
FI945780A (fi) 1994-12-08
NZ253308A (en) 1995-11-27

Similar Documents

Publication Publication Date Title
DE69329574T2 (de) Pharmazeutisch wirksame bicyclisch heterocyclische amine
SI9300309A (sl) Novi biolosko ucinkoviti derivati eburnamenina, farmacevtski pripravki, ki jih vsebujejo, in postopek za njihovo pripravo
DE69718177T2 (de) Substituierte pyrimidinderivate und ihre pharmazeutische anwendung
US4996318A (en) Amino-9,10-secosteroids useful for treating head injury, spinal cord trauma or stroke
EP3584239A1 (en) O-aminoheteroaryl alkynyl-containing compound, preparation method therefor, and use thereof
EP2872524B1 (de) 3-substituierte estra-1,3,5 (10),16-tetraen-derivate, verfahren zu ihrer herstellung, pharmazeutische präparate die diese enthalten, sowie deren verwendung zur herstellung von arzneimitteln
US5547949A (en) Steroids with pregnane skeleton, pharmaceutical compositions containing them
HU212133B (en) Therapeutic agents
US4256886A (en) Process for the preparation of oxadiazolopyrimidine derivatives
WO1987007895A1 (en) Androstane-type and cortical aminoesters
DE2804519C2 (et)
DE3150486A1 (de) Imidazo(4,5-c)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
US5099019A (en) Amines useful in producing pharmaceutically active CNS compounds
US4150132A (en) Oxadiazolopyrimidine derivatives
JPH03246282A (ja) トリアゾリルヒドラジド誘導体、その製造方法、およびその誘導体を活性成分とする抗狭心症または胃潰瘍防止用製剤組成物とその製造方法
EP0665238B1 (en) Corticoid derivatives and pharmaceutical and cosmetic compositions
NO771697L (no) Fremgangsm}te for fremstilling av fysiologisk aktive isotiourinstoffer
DK175347B1 (da) Aminosubstitueret steroid, Delta9(11)-steroid og amin samt farmaceutisk acceptable salte, hydrater og solvater deraf
LT3071B (en) Novel steroids with pregnane skeleton,pharmaceutical compositions containing them and process for preparing thereof
USRE35053E (en) Amines useful in producing pharmaceutically active CNS compounds
HU212310B (hu) Eljárás biológiailag aktív, új androsztán-származékok és ezeket hatóanyagként tartalmazó gyógyszerkészítmények előállítására
NZ217478A (en) Steroids with 20- and 21-amino substitution
HU212419B (en) Process for producing biologically active amino-steroids with androstane-and estrane-structure and pharmaceutical compositions containing the same